Please use this identifier to cite or link to this item:
|標題:||Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate||作者:||Chiou, S.Y.
|關鍵字:||butyrylcholinesterase;acetylcholinesterase;carbamates;activator;inhibitor;structure-reactivity relationships;steady-state kinetics;cholesterol;esterase;molecular recognition;cholinesterases;site;mechanism;binding;hydrolysis;rivastigmine||Project:||Journal of Biochemical and Molecular Toxicology||期刊/報告no：:||Journal of Biochemical and Molecular Toxicology, Volume 21, Issue 1, Page(s) 24-31.||摘要:||
Carbamates are used to treat Alzheimer's disease. These compounds inhibit acetylcholinesterase and butyrylcholinesterase. The goal of this work is to use the substrate analogs of butyrylcholinesterase, 3,3-dimethylbutyl-N-n-butylcarbamate (1) and 2-trimethylsilyl-ethyl-N-n-butylcarbamate (2) to probe the substrate activation mechanism of butyrylcholinesterase. Compounds 1 and 2 are characterized as the pseudo substrate inhibitors of acetylcholinesterase; however, compounds 1 and 2 are characterized as the essential activators of butyrylcholinesterase. Therefore, compounds 1 and 2 mimic the substrate in the acetylcholinesterase-catalyzed reactions, but the behavior of compounds 1 and 2 mimics the substrate activation in the butyrylcholinesterase-catalyzed reactions. (c) 2007 Wiley Periodicals, Inc.
|Appears in Collections:||化學系所|
Show full item record
TAIR Related Article
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.